Patient case study: Navigating treatment options for HR+/HER2- Early Breast Cancer

Patient case study: Navigating treatment options for HR+/HER2- Early Breast Cancer is organized by Springer Healthcare IME.

Description:
In this case study module, Roberto Hegg discusses the current treatment guidelines and emerging therapies for HR+/HER2- early breast cancer, and the most appropriate management approaches based on the identified recurrence risk factors, with reference to the treatment of a 43-year old HR+/HER2- early breast cancer patient.

Learning objectives:
After completing this activity, you will be able to:

• Describe the most appropriate first-line treatment options based on risk of recurrence
• Explain the most appropriate subsequent-line treatment options based on residual risk